Formation Bio
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
The evidence says Formation Bio targets early-stage therapies with AI, has partnered with Novartis and Eli Lilly, and raised substantial funding. That positions it as a useful strategic financing or collaboration target for an AI-driven longevity compounds platform.